Home Alnara Pharmaceuticals

Alnara Pharmaceuticals

In operation
Series B
A company that develops and commercializes oral protein therapeutics.

Basic Information

Alnara Pharmaceuticals, Inc. is committed to developing novel protein therapies for the treatment of metabolic diseases. The company's innovative approach focuses on designing effective protein therapies that can be directly delivered orally to the gastrointestinal tract without being absorbed into the bloodstream.
Alnara Pharmaceuticals, Inc.
United States of America
15~50 people
January 01, 2008
info@alnara.com